Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 20, 2020

SELL
$4.0 - $21.53 $272 - $1,464
-68 Closed
0 $0
Q2 2019

Jul 17, 2019

BUY
$16.27 - $20.51 $1,106 - $1,394
68 New
68 $1,000
Q4 2018

Jan 22, 2019

SELL
$12.41 - $22.98 $29,399 - $54,439
-2,369 Closed
0 $0
Q1 2018

Apr 25, 2018

BUY
$2.99 - $4.44 $7,083 - $10,518
2,369 New
2,369 $7,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $185M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Toth Financial Advisory Corp Portfolio

Follow Toth Financial Advisory Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Toth Financial Advisory Corp with notifications on news.